Effects of hyperbaric therapy on liver morphofunctional of rabbits (Oryctolagus cuniculus) after hind limb ischemia-reperfusion injury by Lukiswanto, Bambang Sektiari et al.




Veterinary World, EISSN: 2231-0916 1337
Veterinary World, EISSN: 2231-0916
Available at www.veterinaryworld.org/Vol.10/November-2017/10.pdf
RESEARCH ARTICLE
Open Access
Effects of hyperbaric therapy on liver morphofunctional of rabbits 
(Oryctolagus cuniculus) after hind limb ischemia-reperfusion injury
Bambang Sektiari Lukiswanto1, Wiwik Misaco Yuniarti1 and Y. Yosis Motulo2
1. Department of Veterinary Clinic, Faculty of Veterinary Medicine, Universitas Airlangga, Jl. Mulyorejo, Kampus C,
Surabaya 60115, Indonesia; 2. Department of Surgery, Division of Thoracic, Cardiac, and Vascular Surgery, Dr. Soetomo 
General Hospital, Surabaya 60115, Indonesia.
Corresponding author: Bambang Sektiari Lukiswanto, e-mail: bamsekti@yahoo.com
Co-authors: WMY: wiwikmisaco@yahoo.com, YYM: yosis_motulo@yahoo.com
Received: 11-06-2017, Accepted: 18-10-2017, Published online: 14-11-2017
doi: 10.14202/vetworld.2017.1337-1342 How to cite this article: Lukiswanto BS, Yuniarti WM, Motulo YY (2017) Effects of 
hyperbaric therapy on liver morphofunctional of rabbits (Oryctolagus cuniculus) after hind limb ischemia-reperfusion injury, 
Veterinary World, 10(11): 1337-1342.
 Abstract
Aim: The objective of this research was to study and to prove the effectiveness of hyperbaric oxygen therapy (HBOT) 
starting time on liver morphofunctional changes after ischemia-reperfusion in the hind limb of rabbits.
Materials and Methods: This research used a complete randomized design with 4 groups and 6 repetitions on each. After 
6 h artery femoral is ligation, reperfusion was performed for 100 min (G1), HBOT for 90 min after 10 min reperfusion 
(G2), 10 min reperfusion (G3), and HBOT 90 min after 60 min reperfusion (G4). Then, all of the rabbits were sacrificed. 
The liver and blood were taken for histopathological changes examination as well as for measuring the level of aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT). The statistical test using Kruskal–Wallis and Mann–Whitney 
showed that the score of degeneration, necrosis, and portal inflammation in groups without HBOT (G1 and G3) were not 
significantly different, as well as in group with HBOT (G2 and G4) (p>0.05). However, the scores of histopathological 
changes in G1 and G3 were significantly different from those in G2 and G4 (p<0.05). The levels of AST and ALT in the 
groups without hyperbaric therapy (G1 and G3) were not significantly different from those in the groups treated with 
hyperbaric therapy (G2 and G4) (p>0.05).
Results: Hind limb ischemia injury reperfusion can trigger damage for liver morphology, but not lead to liver 
dysfunction. Reperfusion can trigger increased activity of neutrophils, while neutrophil infiltration in the organ will lead 
to dysfunction. HBOT can inhibit the activity of neutrophils and the dysfunction of organs caused by ischemic reperfusion.
Conclusion: HBOT for 90 min, both 10 and 60 min after the reperfusion, can protect hepatocytes from damage.
Keywords: hyperbaric oxygen therapy, ischemia, liver, morphofunctional, reperfusion.
Introduction
Ischemic condition can occur in a wide variety 
of disease status. Nevertheless, an ischemic condition 
often occurs in a variety of surgical procedures such as 
in a surgical process of vascular or organ transplanta-
tion. In such circumstances, ischemic injury can occur 
when blood flow to a tissue is reduced or stopped 
in a long time, resulting changes in the metabolism 
of muscles, from aerobic state into anaerobic one. 
Consequently, adenosine triphosphate (ATP) deple-
tion and calcium (Ca) extracellular transfer into mus-
cle cells occur, leading to abnormalities in metabolism 
and thrombosis, as well as tissue inflammation [1].
Blood flow improvement (reperfusion) is 
the main effort to overcome tissue ischemia (isch-
emia-reperfusion [IR]). However, reperfusion has 
negative side effects because it can cause damage and 
impaired organ function when it is not given appro-
priately. Inappropriate reperfusion then can trigger 
activation of proinflammatory mediators as well as 
formation of reactive oxygen species (ROS), resulting 
injury to the tissue [2]. In severe ischemic conditions, 
excessive inflammatory response after reperfusion 
can lead to a systemic inflammatory response syn-
drome and multiple organ dysfunction syndrome 
(MODS) [3]. MODS generally starts from the lungs 
and then spreads to the liver, gastrointestinal tract, and 
kidneys. Bone marrow and liver dysfunctions are in 
the final stages of MODS. Meanwhile, the dysfunc-
tion of the nervous system can occur at the beginning 
or end of MODS [4].
Many researchers actually have already been 
conducted on the effects of various drugs in reducing 
the negative impacts of reperfusion. Those previous 
researchers focused on the impacts of reperfusion 
used hyperbaric oxygen therapy (HBOT), a method of 
therapy using 100% oxygen with a high atmospheric 
pressure in a special room. HBOT has been proved 
to be very helpful to reduce the negative impacts of 
reperfusion in various tissues by reducing the activ-
ity of mediators of inflammation and oxidative stress 
induced by the reperfusion process [5].
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Unfortunately, there have not been a lot of 
researchers aimed to know the appropriate time for the 
administration of HBOT in patients with various organ 
function disorders after reperfusion, especially its 
impact on liver organ. In patients with stroke, HBOT 
is known to be effective if given exactly 3 h after 
reperfusion since if given more than 3 h, it will not 
give any effect [6]. This research aimed to investigate 
effects of time-based HBOT administration on liver 
morphofunctional state of rabbits (Oryctolagus cunic-
ulus) as animal models after hind limb reperfusion.
Materials and Methods
Ethical approval
This research was conducted under the ethi-
cal use of laboratory animals and also was approved 
by the Ethical Committee of Faculty of Veterinary 
Medicine, Universitas Airlangga.
Research sites
This research was conducted at the Faculty of 
Veterinary Medicine, Universitas Airlangga, and also 
at the Department of Underwater and Hyperbaric 
Medicine, Hospital Dr. Ramelan, Surabaya. 
Preparations for histopathological examination and 
blood tests were made in the Department of Pathology 
and Veterinary Hospital, Faculty of Veterinary 
Medicine, Universitas Airlangga, Surabaya.
Experimental animals
Experimental animals used in this research were 
24 male New Zealand rabbits aged 6 months old and 
weighed 2-2.5 kg. Most studies use male animal mod-
els because of their stable hormonal status during 
treatment, and these animals are not at risk of being 
affected by hormonal (estrogen/progesterone) fluc-
tuation related to the reproductive cycle that may 
confound the results of the study. Reperfusion injury 
using the rabbit as animal model showed significantly 
less infarct in female hearts as compared to males [7].
Research materials
Materials used in this research were mineral 
water and food for rabbits, 70% alcohol, 10% ket-
amine, 2% xylazine hydrochloride, atropine sulfate, 
sterile thump, 10% buffered formalin, materials for 
staining hematoxylin-eosin (HE), materials for aspar-
tate aminotransferase (AST) and alanine aminotrans-
ferase (ALT) examinations, and materials for the 
euthanasia of rabbits at the end of the research.
Research tools
Tools used in this research were rabbit hutches, 
minor surgery equipment, masks, gloves, 10 cc 
syringe, syringes 3 cc, silastic band, hyperbaric cham-
ber, a place to store organs, light microscope, object, 
cover glass, as well as blood container tube without 
anticoagulants.
Experimental animal preparation
Those rabbits were adapted for 1 week before the 
research. They were fed and given to drink ad libitum. 
Next, femoral artery ligation was conducted on all the 
experimental animals. They were then divided into 
four groups, namely, G1, G2, G3, and G4.
Afterward, before anesthesia was conducted for 
surgery, all those rabbits were fasted for 12 h. Next, 
anesthesia was performed by weighing each rabbit 
and then injecting them with 0.02 mg/kg of atropine 
sulfate intramuscularly. After 10 min, anesthesia 
was carried out by injecting a combination of ket-
amine-xylazine with doses of 35 mg/kg and 5 mg/kg 
intramuscularly [7].
Although 30-50% of rabbits produce endogenous 
atropinase enzymes, because using atropine sulfate 
0.1-0.2 mg/kg bw/sc, im. in some studies often help-
ful to decrease salivary production, bronchial secre-
tion and preventing the occurrence of vagal which can 
cause bradycardia [8].
After all of those rabbits were anesthetized, an 
incision was made in the groin area of their sinister. 
Next, dissection was performed to separate the fem-
oral artery from the nerve and the vein. Ischemia was 
induced by ligating the femoral artery with silastic 
band for 6 h, then followed with reperfusion by open-
ing or removing the ligation to restore normal blood 
circulation in accordance with the treatment group.
Group 1 (G1): Femoral artery ligation for 6 h, 
followed with reperfusion by releasing ligation for 
100 min (IR 100 min).
Group 2 (G2): Ligation for 6 h, followed with 
reperfusion by releasing ligation for 100 min. HBOT 
was given 10 min after the reperfusion for 90 min 
(IR 100 min with HBOT 90 min).
Group 3 (G3): Ligation for 6 h, followed 
with reperfusion by releasing ligation for 150 min 
(IR 150 min).
Group 4 (G4): Ligation for 6 h, followed 
with reperfusion by releasing ligation for 150 min. 
Hyperbaric therapy was given 60 min after the reper-
fusion for 90 min (IR 150 min with HBOT 90 min).
At the end of the research, all the rabbits were 
sacrificed. Their liver and blood were taken for exam-
ining histopathological changes in their liver using 
HE staining as well as for measuring the levels of AST 
and ALT. Histopathological changes were evaluated 
to assess the degree of liver damage as a result of the 
treatment given. Scoring method used in this research 
was a modification of Knodell method [9]. The type 
Figure-1: Congestion on group 3.
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of the lesions observed and scoring technique used are 
as following:
Type of 
lesions
Score Note
Necrosis 0 No necrosis
1 Necrosis on 1/3 of lobular
3 Necrosis on 1/3-2/3 of lobular
4 Necrosis on >2/3 of lobular
5 Necrosis on 1/3-2/3 of 
lobular+bridging necrosis
6 Necrosis on >2/3 of lobular+bridging 
necrosis
10 Multilobular necrosis
Degeneration 0 No Degeneration
1 Degeneration on 1/3 of lobular
3 Degeneration on 1/3-2/3 of lobular
4 Degeneration on >2/3 of lobular
Portal 
inflammation
0 No inflammation
1 Light inflammation on 1/3 of lobular
3 Mild inflammation on 1/3-2/3 of 
lobular
4 Severe inflammation on >2/3 of 
lobular
Congestion 0 No hemorrhage
1 Light (hemorrhage on 1/3 of lobular)
2 Mild (hemorrhage on 1/3-2/3 of 
lobular)
3 Severe (hemorrhage on >2/3 of 
lobular)
Results
Scoring of histopathological changes in the liv-
ers was focused on necrotic lesions, degeneration, 
portal inflammation, and congestion. The results 
showed that within groups without hyperbaric therapy 
(G1 and G3), the scores of necrosis, degeneration, and 
portal inflammation were not significantly different 
(p>0.05). Similarly, within groups with hyperbaric 
therapy, namely, G2 and G4, the scores of necrosis, 
degeneration, and portal inflammation were not sig-
nificantly different (p>0.05). However, the scores of 
histopathological changes in G1 and G3 were signifi-
cantly different from those in G2 and G4 (p<0.05).
Moreover, scoring results of congestion degree 
had a different pattern, in which there was no conges-
tion in G1, G2, and G4. Unlike the other three groups, 
congestion only appeared in G3 (p<0.05) (Figure-1). 
The degree of the total score (necrosis, degeneration, 
and portal inflammation) in the group without hyper-
baric therapy was higher than in the group with hyper-
baric therapy (Figures-2-4 and Table-1).
Differences in the scoring results of histopatho-
logical changes between the groups without hyperbaric 
therapy, furthermore, did not seem affected by the length 
of reperfusion duration. For instance, there was no dif-
ference in histopathological scoring results and AST/
ALT levels between Group G2 and Group G4 although 
both had different reperfusion duration, namely, 10 and 
60 min before the administration of hyperbaric therapy.
In addition, results of the analysis of AST and 
ALT levels in each treatment group also showed a 
different pattern of results derived from the scoring 
results of histopathological changes in the livers. The 
results showed that the levels of AST and ALT in the 
groups without hyperbaric therapy (G1 and G3) were 
not significantly different from those in the groups 
treated with hyperbaric therapy (G2 and G4) (p>0.05) 
(Table-2). The levels of AST/ALT in all treatment 
groups, nevertheless, were still within normal values 
of AST/ALT levels in rabbits.
Figure-2: Degeneration of hepatocyte on each group.
Figure-3: Necrosis of hepatocyte on each group.
Figure-4: Portal inflammation on each group.
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Discussion
Hepatic ischemia-reperfusion injury is a multi-
factorial pathophysiological process. Numerous stud-
ies have shown that this process includes excessive 
intracellular Ca, increased free oxygen radical, and 
increased of apoptosis or necrotic liver parenchy-
mal cells [10,11]. The presence of oxidatives stress 
caused disturbances in the cell cycle and initiates 
apoptosis [12].
In this research, necrotic, degenerative, and 
inflammatory lesions on those livers were not accom-
panied with changes in the function of those livers 
by examining the levels of AST/ALT. This may be 
caused by the degree of hepatocyte damage classified 
into mild to moderate one. In addition, it can also be 
caused due to compensatory mechanism owned by 
those livers, where healthy hepatocytes would take 
over the function of hepatocytes suffering from the 
injury.
Similarly, a previous research also showed that 
limb ischemia suffered by mice for 2 h, then followed 
by reperfusion can cause injury to their lungs, but not 
in their liver and kidneys [13]. Unlike in the previous 
research, other researchers have also shown that limb 
ischemia suffered by mice for 3 h, then followed by 
reperfusion can cause injury to their lungs and kid-
neys, as well as the muscle of their lower limb [14,15].
Studies conducted directly with hepatic isch-
emia-reperfusion injury (HIRI) showed that this treat-
ment cause hepatocytes apoptosis accompanied by ele-
vate levels of AST and ALT, reflect severe hepatocyte 
damage [10,11]. These facts support an assumption 
that many negative effects of IR can trigger ischemia 
injury to vital organs near the ischemic area. Therefore, 
it can certainly be said that the improvement in the 
histopathological feature of G2 and G4 is not due to 
self-limited, but due to HBOT therapy given since IR 
was conducted 6 h after the induction of ischemia.
Vital organs, including liver, are very sensi-
tive to ischemia that occurs on injury due to IR. 
Ischemia-reperfusion is usually accompanied by oxi-
dative stress and then continued with stimulation of 
inflammatory response, eventually leading to injury to 
the liver [16]. Oxidation and inflammatory are media-
tors for the occurrence of injury in various organs after 
IR, which will end with a dysfunction of the organs, 
including liver [17].
Various factors, such as oxygen free radicals, 
migration and activation, abnormalities in the micro-
circulation, damage to endothelial cells sinusoid, 
coagulation cascade activation, and Kupffer cell activ-
ities to release inflammatory mediators and proteolytic 
enzymes, plays a role in causing injury to the liver due 
to IR [18,19]. Lesions on the liver caused by IR can 
occur in two phases, causing damage to hepatocytes. 
First, acute phase is characterized by the production 
of ROS by Kupffer cells, causing mild injury in the 
hepatocytes. In the next phase, there will be infiltra-
tion of leukocytes to the area of injury as a form of 
inflammatory cascade commencement. Neutrophil 
accumulation in the liver may cause injury to hepato-
cytes through oxidants and proteases released by 
neutrophils [20]. ROS after reperfusion in the initial 
phase is considered to have an important role in initi-
ating and aggravating oxidative stress in the liver after 
reperfusion [21].
In this research, furthermore, HBOT could 
improve morphological function of liver, namely, in 
Group G2 and Group G4. On the other hand, accord-
ing to Kihara [22], HBOT can trigger increased activ-
ity of neutrophils, while neutrophil infiltration in the 
organ will lead to dysfunction. In such conditions, 
HBOT can inhibit the activity of neutrophils, and the 
dysfunction of organs caused.
Da Silveira et al. [23] stated that the supply of oxy-
gen after reperfusion can act as a protector of mitochon-
drial membrane. Oxygen is an agent that plays a role 
in the formation of ATP by oxidative phosphorylation. 
The energy generated is very necessary for the flow 
of both various ions out of the mitochondria as well 
as liquid into the mitochondria through the mitochon-
drial membrane. This process then will help to decrease 
the production and release of ROS, so the mitochon-
dria can function normally. Therefore, an imbalance in 
this process can make oxidative damage become more 
extensive. This similar condition was also found in 
Group G1 and Group G3, experiencing ischemia in the 
same period without the administration of HBOT.
Biochemistry profile parameters, including 
AST/ALT, in rabbits, were influenced by various 
Table-1: Scoring results of histopathological changes in the livers (mean±SD) of each treatment group.
Treatment group Necrosis Degeneration Inflammation portal Congestion
G1 1.2b±0.2 1.0b±0.0 1.1b±0.6 0.0a±0.0
G2 0.8a±0.2 0.3a±0.1 0.5a±0.1 0.0a±0.0
G3 1.3b±0.17 0.9b±0.5 1.1b±0.6 0.3b±0.1
G4 1.0a±0.00 0.5a±0.1 0.6a±0.0 0.0a±0.0
Means with different superscripts letters are significant at p<0.05. SD=Standard deviation
Table-2: Levels of AST and ALT in each group.
Treatment group AST (IU/L) ALT (IU/L)
G1 36.76a±3.11 12.60a±0.67
G2 38.08a±3.11 13.07a±0.67
G3 42.32a±3.11 12.05a±0.67
G4 40.07a±3.11 12.30a±0.67
Means with different superscripts letters are significant at 
p<0.05. AST=Aspartate aminotransferase, ALT=Alanine 
aminotransferase
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factors such as breed, age, sex, feed, liver disease, 
environmental conditions, stress, pregnancy, and 
heart rhythm [24-27]. Nevertheless, in this research, 
there was no difference in AST/ALT level between 
the rabbits without treatment and the rabbits with 
hyperbaric-treatment. In other words, all of those 
rabbits had no liver function impairment. Research 
on pigs was subjected left hemihepatectomy suggests 
that portal vein arterialization promotes early and 
improved liver regeneration without impairing liver 
function [28].
Conclusion
Hind limb ischemia injury reperfusion can trig-
ger a damage for liver morphology, but not lead to 
liver dysfunction. HBOT for 90 min, 10-60 min after 
the reperfusion, can protect hepatocytes from damage.
Authors’ Contributions
BSL and YM carried out the main research 
works, WMY performed the statistical analysis and 
analyzed the main data in the experiments and BSL, 
WMY and YM approved the final manuscript. All 
authors read and approved the final manuscript.
Acknowledgments
The authors are very thankful to Faculty 
of Veterinary Medicine, Universitas Airlangga; 
Department of Surgery, Division of Thoracic, Cardiac, 
and Vascular Surgery, Dr. Soetomo General Hospital, 
Surabaya; and the Department of Underwater and 
Hyperbaric Medicine, Dr. Ramelan Naval Hospital, 
Surabaya, for providing all the type of facilities to 
conduct this research.
Competing Interests
The authors declare that they have no competing 
interests.
References
1. Fiolet, J.W.T. and Baartscheer, A. (2000) Update review 
cellular calcium homeostasis during ischemia: A thermody-
namic approach. Cardiovasc. Res., 45: 100-106.
2. Neil-Granger, D. and Kvietys, P.R. (2015) Reperfusion 
injury and reactive oxygen species: The evolution of a con-
cept. Redox Biol., 6: 524-551.
3. Jaffer, U., Wade, R.G. and Gourlay, T. (2010) Cytokines in 
the systemic inflammatory response syndrome: A review. 
HSR Proc. Intensive Care Cardiovasc. Anesth., 2(3): 
161-175.
4. Gyurkovics, E., Aranyi, P., Stangl, R., Onody, P., 
Ferreira, G., Lotz, G., Kupcsulik, P. and Szijarto, A. (2011) 
Post conditioning of the lower limb-protection against the 
reperfusion syndrome. J. Surg. Res., 169(1): 139-147.
5. Bozok, S., Ilhan, G., Yilmaz, Y., Dokumcu, Z., Tumkaya, L., 
Karamustafa, H., Ozan, K., Karakisi, S., Ergene, S. and 
Şener, E. (2012) Protective effects of hyperbaric oxygen 
and iloprost on ischemia/reperfusion-induced lung injury in 
a rabbit model. Eur. J. Med. Res., 17(1): 14.
6. McCormick, J.G., Houle, T.T., Saltzman, H.A., Whaley, R.C. 
and Roy, R.C. (2011) Treatment of acute stroke with hyper-
baric oxygen: Time window for efficacy. Undersea Hyperb. 
Med., 38: 321-334.
7. Mahmoodzadeh, S., Fliegner, D. and Dworatzek, D. (2012) 
Sex differences in animal models for cardiovascular dis-
eases and the role of estrogen. Handb. Exp. Pharmacol., 
214: 23-48.
8. Flecknell, P. (2009) Laboratory Animal Anaesthesia. 3rd ed. 
Academic Press, USA. p204-210.
9. Brunt, E. (2000) Grading and staging the histopathological 
lesions of chronic hepatitis: The knodell histology activity 
index and beyond. Hepatology, 31: 241-246.
10. Yang, J., Sun, H., Takacs, P., Zhang, Y., Liu, J., Chang, Y. 
and Candiotii, K.A. (2013) The effect of octreotide on 
hepatic ischemia-reperfusion injury in a rabbit model. 
Transplant. Proc., 45: 2433-2438.
11. Weigand, K., Brost, S., Steinebrunner, N., Buchler, M., 
Schemmer, P. and Muller, M. (2012) Ischemia reperfusion 
injury in liver surgery and transplantation: Patophysiology. 
HPB Surg., 2012: 1-9.
12. Vali, L., Taba, G., Szentmihalyi, K., Febel, H., Kurucs, T., 
Pallai, Z., Kupcsulik, P. and Blazovics, A. (2006) Reduced 
antioxidant level and increased oxidative damage in 
intact liver lobes during ischemia reperfusion. World J. 
Gastroenterol., 21: 1086-1091.
13. Mansour, Z., Charles, A.L., Kindo, M., Pottecher, J., 
Chamaraux-Tran, T.N., Lejay, A., Zoll, J., Mazzucotelli, J.P. 
and Geny, B. (2014) Remote effects of lower limb ischemia 
reperfusion: Impaired lung, unchanged liver, and stimulated 
kidney oxidative capacities. Biomed. Res. Int., 4: 390-392.
14. Kao, M.C., Yang, C.H., Chou, W.C., Sheu, J.R. and 
Huang, C.J. (2015) Cepharanthine mitigates lung injury 
in lower limb ischemia-reperfusion. J. Surg. Res., 
199: 647-656.
15. Kao, M.C., Chung, C.Y., Chang, Y.Y., Lin, C.K., Sheu, J.R. 
and Huang, C.J. (2015) Salutary effects of cepharanthine 
against skeletal muscle and kidney injuries following limb 
ischemia/reperfusion. Evid. Based Complement. Alternat. 
Med., 50: 40-46.
16. Duehrkop, C., De noyelle, J., Shaw, S. and Rieben, R. 
(2014) Use of dextran sulfate in tourniquet-induced skeletal 
muscle reperfusion injury. J. Surg. Res., 187: 150-161.
17. Chang, Y.K., Huang, S.C., Kao, M.C. and Huang, C.J. (2016) 
Cepharanthine alleviates liver injury in a rodent model 
of limb ischemia-reperfusion. Acta Anaesthesiologica 
Taiwanica, 54: 11-15.
18. Serracino-Inglott, F., Habib, N.A. and Mathie, R.T. 
(2001) Hepatic ischemia-reperfusion injury. Am. J. Surg., 
181: 160-166.
19. Giakoustidis, D., Papageorgiou, G., Iliadis, S., Kontos, N., 
Kostopoulou, E., Papachrestou, A., Tsantilas, D., 
Spyridis, C., Takoudas, D., Botsoglou, N., Dimitriadou, A. 
and Giakoustidis, E. (2002) Intramuscular administra-
tion of very high dose of alpha-tocopherol protects liver 
from severe ischemia/reperfusion injury. World J. Surg., 
26: 872-877.
20. Okaya, T. and Lentsch, A.B. (2003) Cytokine cascades and 
the hepatic inflammatory response to ischemia and reperfu-
sion. J. Invest. Surg., 16(3): 141-143.
21. Furukawa, H., Hayashi, T. and Todo, S. (2000) A novel 
hydroxyl radical scavenger, nicaraven, protects the liver 
from warm ischemia and reperfusion injury. Surgery, 
127: 661-669.
22. Kihara, K., Ueno, S., Sakoda, M. and Aikou, T. (2005) 
Effects of hyperbaric oxygen exposure on experimental 
hepatic ischemia reperfusion injury: Relationship between 
its timing and neutrophil sequestration. Liver Transplant., 
11: 1574-1580.
23. Silveira, M.R.G., Margarido, M.R., Vanni, J.C., Junior, R.N. 
and Silva, O. (2014) Effects of hyperbaric oxygen ther-
apy on the liver after injury caused by the hepatic isch-
emia-reperfusion process. Acta Cirúrgica Brasileira, 29(1): 
29-33.
24. Chineke, C.A., Ologun, A.G. and Ikeobi, C.O.N. (2006) 
Haematological parameters in rabbit breeds and crosses in 
humid tropics. Pak. J. Biol. Sci., 9: 2102-2106.
Veterinary World, EISSN: 2231-0916 1342
Available at www.veterinaryworld.org/Vol.10/November-2017/10.pdf
25. Melillo, A. (2007). Rabbit clinical pathology. J. Exot. Pet 
Med., 16: 135-145.
26. Jeklova E., Leva L., Knotigova P. and Faldyna, M. (2009) 
Age-related changes in selected haematology parameteres 
in rabbits. Res. Vet. Sci., 86: 525-528.
27. Abdel-Azeem, A.S., Abdel-Azim, A.M., Darwish, A.A. and 
Omar E.M. (2010) Haematological and biochemical obser-
vations in four pure breeds of rabbits and their crosses under 
********
Egyptian environmental conditions. World Rabbit Sci., 
18: 103-110.
28. Ott, R., Schuppan, D., Tannapfel, A., Wittekind, C., 
Erhardt, W., Henke, J., Kilic, N., Kockerling, F., Reck, T., 
Hohenberger, W. and Muller, W. (2003) Portal vein arterial-
ization as a technical option in liver transplantation: Impact 
on function, regeneration, and morphology of the liver fol-
lowing hemihepatectomy in pigs. Liver Int., 23: 54-62.
